{"id": "1387844137291063296", "creation": 1619722801.0, "user_id": "18026170", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Mixed results for #Celltrion\u2019s #COVID19 #vaccine vs #SARSCoV2 B.1.351 #variant\n\nIn vitro, CT-P59 had lower affinity to #spike #RBD &amp; lower #neutralizing activity, but it decreased viral load in #ferret #challenge\n\nhttps://t.co/XrzAk6ufGg\n#InfectiousDiseases @biorxivpreprint https://t.co/5lIoX8FjvM", "first_save": 1634559108.199414, "hashtags": ["#CELLTRION", "#COVID19", "#VACCINE", "#SARSCOV2", "#VARIANT", "#SPIKE", "#RBD", "#NEUTRALIZING", "#FERRET", "#CHALLENGE", "#INFECTIOUSDISEASES"]}